AcademiaAdvance research and accelerate real-world outcomes
Advance research and accelerate real-world outcomes
CorporateDrive innovation and build strong brands
Drive innovation and build strong brands
GovernmentMaximize the impact of your country’s research and innovation
Maximize the impact of your country’s research and innovation
Legal ServicesEvolve your practice and maximize growth potential
Evolve your practice and maximize growth potential
Life Sciences and HealthcareAdvance innovation and accelerate patient outcomes
Advance innovation and accelerate patient outcomes
Scientific & Academic Researcharrow_forward
Discovery & Workflow
Analytics, Evaluation & Management
Discovery, Clinical & Regulatory
Portfolio Strategy & Business Development
Commercial & Launch Strategy
Strategic Portfolio Planning
Product Lifecycle Management
IP Litigation Intelligence Solutions
Patent Intelligence Software
Patent Search & Analytics
Trademark Research & Protection
Chemistry & Life Science
IP Data & APIs
IP Lifecycle Managementarrow_forward
Patent & Trademark Management Software
Network Collaboration Tools
Patent & Trademark Maintenance
Filing & Prosecution Support
Patent Translations Services
Consulting & Dataarrow_forward
Research Intelligence Cloud
Real World Data
BlogKeep up with the latest news, insights and research from Clarivate.
Keep up with the latest news, insights and research from Clarivate.
Clarivate Innovation ExchangeThe Clarivate Innovation Exchange accelerates research, development and commercialization.
The Clarivate Innovation Exchange accelerates research, development and commercialization.
Partnersarrow_forwardPartner with us and help accelerate innovation.
Partner with us and help accelerate innovation.
Cortellis Partner Program
ScholarOne Partner Program
Researcher RecognitionWorld-changing research should be seen, shared and celebrated.
World-changing research should be seen, shared and celebrated.
Academic & Government
Life Sciences & Healthcare
Reports & Case Studiesarrow_forward
ISI Global Research Reports
Life Sciences and Healthcare
Scientific & Academic Research
IP Lifecycle Management
Consulting & Data
Clarivate Innovation Exchange
Reports & Case Studies
CAR T-cell therapies, including Novartis’s Kymriah, Gilead / Kite’s Yescarta and Tecartus, and Celgene / Bristol Myers Squibb’s Breyanzi, have given new hope to patients with relapsed/…
Clarivate expects the next ten years to be transitional for patients with hemophilia A, with and without inhibitors, as both the number of therapy options and size of the hemophilia market increase…
Heart failure (HF) is classified as acute or chronic, and both settings are the focus of this report. Although much progress has been made in the pharmacological management of HF, it mainly relates…
The treatment landscape for COVID-19 continues to evolve rapidly. Even with vaccines having become available in the markets under study, intense ongoing research has also focused on approaches…
Metastatic squamous non-small-cell lung cancer (NSCLC) is an aggressive form of lung cancer with poor survival outcomes. First-line treatment is limited to chemotherapy or immune checkpoint…